Roivant Sciences Ltd - Kinevant to Discontinue Namilumab Development for Sarcoidosis
Roivant Sciences Ltd - Kinevant決定終止Namilumab在結節病治療中的研發
Roivant Sciences Ltd - Kinevant to Discontinue Namilumab Development for Sarcoidosis
Roivant Sciences Ltd - Kinevant決定終止Namilumab在結節病治療中的研發
譯文內容由第三人軟體翻譯。